News
![Tired businesswoman in the office](https://pharmaphorum.com/wp-content/uploads/2018/07/woman_office_depressed.jpg)
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted